BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 15001945)

  • 21. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.
    Tartaglia M; Kalidas K; Shaw A; Song X; Musat DL; van der Burgt I; Brunner HG; Bertola DR; Crosby A; Ion A; Kucherlapati RS; Jeffery S; Patton MA; Gelb BD
    Am J Hum Genet; 2002 Jun; 70(6):1555-63. PubMed ID: 11992261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noonan-like syndrome mutations in PTPN11 in patients diagnosed with cherubism.
    Jafarov T; Ferimazova N; Reichenberger E
    Clin Genet; 2005 Aug; 68(2):190-1. PubMed ID: 15996221
    [No Abstract]   [Full Text] [Related]  

  • 23. High resolution melting analysis for mutation detection for PTPN11 gene: applications of this method for diagnosis of Noonan syndrome.
    Lo FS; Luo JD; Lee YJ; Shu SG; Kuo MT; Chiou CC
    Clin Chim Acta; 2009 Nov; 409(1-2):75-7. PubMed ID: 19737548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline gain-of-function mutations in SOS1 cause Noonan syndrome.
    Roberts AE; Araki T; Swanson KD; Montgomery KT; Schiripo TA; Joshi VA; Li L; Yassin Y; Tamburino AM; Neel BG; Kucherlapati RS
    Nat Genet; 2007 Jan; 39(1):70-4. PubMed ID: 17143285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel mitochondrial DNA mutations implicated in Noonan syndrome.
    Dhandapany PS; Sadayappan S; Vanniarajan A; Karthikeyan B; Nagaraj C; Gowrishankar K; Selvam GS; Singh L; Thangaraj K
    Int J Cardiol; 2007 Aug; 120(2):284-5. PubMed ID: 17092585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation.
    Araki T; Mohi MG; Ismat FA; Bronson RT; Williams IR; Kutok JL; Yang W; Pao LI; Gilliland DG; Epstein JA; Neel BG
    Nat Med; 2004 Aug; 10(8):849-57. PubMed ID: 15273746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to growth hormone in short children with Noonan syndrome: correlation to genotype.
    Binder G
    Horm Res; 2009 Dec; 72 Suppl 2():52-6. PubMed ID: 20029239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation analysis of PTPN11 in Noonan syndrome by WAVE.
    Elanko N; Jeffery S
    Methods Mol Med; 2006; 126():97-111. PubMed ID: 16930008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome.
    Ferreira LV; Souza SA; Arnhold IJ; Mendonca BB; Jorge AA
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5156-60. PubMed ID: 15956085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and molecular characterization of 40 patients with Noonan syndrome.
    Ferrero GB; Baldassarre G; Delmonaco AG; Biamino E; Banaudi E; Carta C; Rossi C; Silengo MC
    Eur J Med Genet; 2008; 51(6):566-72. PubMed ID: 18678287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel PTPN11 mutation in LEOPARD syndrome.
    Conti E; Dottorini T; Sarkozy A; Tiller GE; Esposito G; Pizzuti A; Dallapiccola B
    Hum Mutat; 2003 Jun; 21(6):654. PubMed ID: 14961557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel PTPN11 gene mutation in a patient with LEOPARD Syndrome.
    Du-Thanh A; Cave H; Bessis D; Puso C; Guilhou JJ; Dereure O
    Arch Dermatol; 2007 Sep; 143(9):1210-1. PubMed ID: 17875892
    [No Abstract]   [Full Text] [Related]  

  • 33. PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome.
    Kosaki K; Suzuki T; Muroya K; Hasegawa T; Sato S; Matsuo N; Kosaki R; Nagai T; Hasegawa Y; Ogata T
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3529-33. PubMed ID: 12161469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
    Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumors.
    Mutesa L; Pierquin G; Janin N; Segers K; Thomée C; Provenzi M; Bours V
    Cancer Genet Cytogenet; 2008 Apr; 182(1):40-2. PubMed ID: 18328949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [PTPN11 gene mutation in LEOPARD syndrome].
    Paradisi M; Pedicelli C; Ciasulli A; Pinto F; Conti E; Sarkozy A; Angelo C
    Minerva Pediatr; 2005 Aug; 57(4):189-93. PubMed ID: 16172598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTPN11 mutations are not responsible for the Cardiofaciocutaneous (CFC) syndrome.
    Kavamura MI; Pomponi MG; Zollino M; Lecce R; Murdolo M; Brunoni D; Alchorne MM; Opitz JM; Neri G
    Eur J Hum Genet; 2003 Jan; 11(1):64-8. PubMed ID: 12529707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory failure, juvenile myelomonocytic leukemia, and neonatal Noonan syndrome.
    Cheong JL; Moorkamp MH
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):262-4. PubMed ID: 17414570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational analysis of PTPN11 gene in Taiwanese children with Noonan syndrome.
    Hung CS; Lin JL; Lee YJ; Lin SP; Chao MC; Lo FS
    J Formos Med Assoc; 2007 Feb; 106(2):169-72. PubMed ID: 17339163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTPN11 mutation in a young man with Noonan syndrome and retinitis pigmentosa.
    Schollen E; Matthijs G; Fryns JF
    Genet Couns; 2003; 14(2):259. PubMed ID: 12872825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.